Document Detail

Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study.
MedLine Citation:
PMID:  9751245     Owner:  NLM     Status:  MEDLINE    
Previous studies indicate that fasting plasma glucose decreases during gestation, but the timing and extent are not consistent from study to study. We had an opportunity to examine this question in the normal pregnancy cohort of women studied in the Diabetes in Early Pregnancy Study. Subjects were monitored to identify pregnancy by human chorionic gonadotropin testing, enrolled within 21 days of conception, and screened to rule out gestational diabetes at the juncture of the second and third trimesters. All subjects were instructed to fast overnight for 10 to 12 hours. Three hundred sixty-one women were studied between 6 and 12 weeks of gestation. A median decrease in plasma glucose of 2 mg/dL was observed between weeks 6 and 10 (P=.007). In a smaller group of subjects evaluated through the third trimester, little further glucose reduction was observed. A reduction in glycosylated hemoglobin levels between 10 and 20 weeks (P=.002) followed the earlier reduction in first trimester glucose levels. Analysis by body mass index (BMI) showed a smaller first trimester reduction with increasing BMI, and none among severely obese women (BMI > 29.9 kg/m2). The decline in fasting plasma glucose in pregnancy begins early in the first trimester, well before fetal glucose requirements can contribute to the decline in the glucose level. Thereafter, plasma glucose levels decrease little. These results suggest that in the setting in which this study was performed (an overnight fast) maternal physiologic adjustments account for a reduction in plasma glucose early in the first trimester of pregnancy, and possibly even later in gestation as well.
J L Mills; L Jovanovic; R Knopp; J Aarons; M Conley; E Park; Y J Lee; L Holmes; J L Simpson; B Metzger
Related Documents :
562785 - Plasma hormone profile of threatened abortion and its prognosis.
9491865 - Total plasma fibronectin as a marker of pregnancy-induced hypertensive disorders: a lon...
2529065 - Plasma concentrations of atrial natriuretic factor in normal pregnancy and early puerpe...
23897005 - Embryo developmental capability and pregnancy outcome are related to the mitochondrial ...
23806115 - Nuchal translucency and cardiac abnormalities in euploid singleton pregnancies.
22122545 - Two successful pregnancies in a patient with chemotherapy-induced ovarian failure while...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  47     ISSN:  0026-0495     ISO Abbreviation:  Metab. Clin. Exp.     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-10-08     Completed Date:  1998-10-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1140-4     Citation Subset:  IM    
Epidemiology Branch and Biometry and Mathematical Statistics Branch, Division of Epidemiology, Statistics and Prevention Research, National Institute of Child Health and Human Development, Bethesda, MD, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / analysis*
Body Mass Index
Hemoglobin A, Glycosylated / analysis
Insulin Resistance
Pregnancy / blood*
Pregnancy Trimester, First
Reg. No./Substance:
0/Blood Glucose; 0/Hemoglobin A, Glycosylated

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Resting metabolic rate in healthy adults: relation to growth hormone status and leptin levels.
Next Document:  Dietary protein restriction alters glucose but not protein metabolism in non-insulin-dependent diabe...